BioMarin Pharmaceutical, Inc. (BMRN)
53.70
-0.04
(-0.07%)
USD |
NASDAQ |
Dec 10, 16:00
53.70
0.00 (0.00%)
After-Hours: 20:00
BioMarin Pharmaceutical Market Cap: 10.32B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Align Technology, Inc. | 11.81B |
| Biogen, Inc. | 26.05B |
| Gilead Sciences, Inc. | 150.54B |
| Regeneron Pharmaceuticals, Inc. | 76.32B |
| Moderna, Inc. | 11.34B |
Market Cap Related Metrics
| PE Ratio | 20.12 |
| PS Ratio | 3.404 |
| PEG Ratio | 0.3314 |
| Price to Book Value | 1.703 |
| Price to Free Cash Flow | 12.72 |
| Price | 53.70 |
| Earnings Yield | 4.97% |
| PEGY Ratio | 0.3314 |
| Operating PE Ratio | 12.28 |
| Normalized PE Ratio | 15.05 |